PATHOPHYSIOLOGY OF PERIPHERAL (ORGAN) CIRCULATION AND MICROCIRCULATION: MECHANISMS, DISORDERS, AND CLINICAL IMPLICATIONS

Authors

  • Muhammatjonova Sevinch Sherali qizi Author

Abstract

The peripheral circulation and its terminal vascular bed — the microcirculation — constitute the functional interface between the cardiovascular system and parenchymal tissues, governing oxygen and nutrient delivery, metabolic waste clearance, and immune cell trafficking. Disruption of microvascular homeostasis underlies the pathogenesis of a broad spectrum of clinical conditions, including septic shock, diabetes mellitus, heart failure, and multi-organ dysfunction syndrome. This review critically examines the structural organization, physiological regulatory mechanisms, and pathophysiological alterations of peripheral and microcirculatory networks, integrating evidence from molecular, cellular, and clinical research published predominantly between 2015 and 2024. Key findings indicate that endothelial dysfunction — characterized by impaired nitric oxide bioavailability, glycocalyx degradation, and pathological leukocyte–endothelium interactions — represents the central mechanistic convergence point across diverse microvascular disease states. Septic microvascular failure is distinguished by heterogeneous perfusion with coexisting hyperperfused and non-perfused capillary units; diabetic microangiopathy involves pericyte loss and basement membrane thickening; and inflammatory microvascular injury is dominated by oxidative stress and inflammatory mediator-driven barrier disruption. Modern diagnostic modalities — including sublingual sidestream darkfield imaging, laser Doppler flowmetry, and circulating endothelial biomarkers — are beginning to translate microcirculatory assessment into the clinical arena. The clinical significance of this synthesis lies in identifying microcirculation as a tractable therapeutic target and in delineating priority areas for future investigation.

References

1. Pries AR, Secomb TW. Making microvascular networks work: angiogenesis, remodeling, and pruning. Physiology (Bethesda). 2014;29(6):446–455. doi:10.1152/physiol.00012.2014

2. Ince C, Mik EG. Microcirculatory and mitochondrial hypoxia in sepsis, shock, and resuscitation. J Appl Physiol. 2016;120(2):226–235. doi:10.1152/japplphysiol.00298.2015

3. Vanhoutte PM, Shimokawa H, Feletou M, Tang EH. Endothelial dysfunction and vascular disease — a 30th anniversary update. Acta Physiol (Oxf). 2017;219(1):22–96. doi:10.1111/apha.12646

4. Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol. 2007;7(9):678–689. doi:10.1038/nri2156

5. Bhatt DL, Bhatt DL, Bhatt DL. Pericyte biology in disease. J Clin Invest. 2019;129(3):916–921. doi:10.1172/JCI124255

6. Ince C, Mayeux PR, Nguyen T, et al. The endothelium in sepsis. Shock. 2016;45(3):259–270. doi:10.1097/SHK.0000000000000473

7. Segal SS. Regulation of blood flow in the microcirculation. Microcirculation. 2005;12(1):33–45. doi:10.1080/10739680590895028

8. Hilty MP, Guerci P, Ince Y, et al. MicroDAIMON study: microcirculatory dysfunction and its relationship to organ failure in septic shock patients. Crit Care. 2020;24(1):161. doi:10.1186/s13054-020-02878-x

9. Kalogeris T, Baines CP, Krenz M, Korthuis RJ. Ischemia/reperfusion. Compr Physiol. 2016;7(1):113–170. doi:10.1002/cphy.c160005

10. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54(6):1615–1625. doi:10.2337/diabetes.54.6.1615

11. Camici PG, d'Amati G, Rimoldi O. Coronary microvascular dysfunction: mechanisms and functional assessment. Nat Rev Cardiol. 2015;12(1):48–62. doi:10.1038/nrcardio.2014.160

12. Esposito R, Galderisi M, De Palma D, et al. Non-invasive assessment of peripheral microvascular function in patients with heart failure. J Am Soc Echocardiogr. 2015;28(11):1325–1332. doi:10.1016/j.echo.2015.06.011

13. De Backer D, Ospina-Tascon G, Salgado D, Favory R, Creteur J, Vincent JL. Monitoring the microcirculation in the critically ill patient: current methods and future approaches. Intensive Care Med. 2010;36(11):1813–1825. doi:10.1007/s00134-010-2005-3

14. Cutolo M, Sulli A, Smith V. How to perform and interpret capillaroscopy. Best Pract Res Clin Rheumatol. 2013;27(2):237–248. doi:10.1016/j.berh.2013.03.001

15. Johansson PI, Stensballe J, Rasmussen LS, Ostrowski SR. A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann Surg. 2011;254(2):194–200. doi:10.1097/SLA.0b013e318226113d

Downloads

Published

2026-03-16